Detection of EGFR Mutations in Plasma cfDNA and Paired CTCs of NSCLC Patients before and after Osimertinib Therapy Using Crystal Digital PCR
Circulating tumor DNA (ctDNA) analysis has clinical utility in EGFR mutant NSCLC. Circulating tumor cells (CTCs) consist a unique source of information at the cellular level. Digital PCR (dPCR) is a valuable tool for accurate and valid analysis of gene mutations in liquid biopsy analysis. In the pre...
Main Authors: | Aliki Ntzifa, Athanasios Kotsakis, Vassilis Georgoulias, Evi Lianidou |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/11/2736 |
Similar Items
-
Circulating Tumor Cells (CTC) and Cell-Free DNA (cfDNA) Workshop 2016: Scientific Opportunities and Logistics for Cancer Clinical Trial Incorporation
by: Lori E. Lowes, et al.
Published: (2016-09-01) -
Non-invasive Technology Advances in Cancer—A Review of the Advances in the Liquid Biopsy for Endometrial and Ovarian Cancers
by: Mark R. Openshaw, et al.
Published: (2020-12-01) -
Genomic Profiling of Uterine Aspirates and cfDNA as an Integrative Liquid Biopsy Strategy in Endometrial Cancer
by: Carlos Casas-Arozamena, et al.
Published: (2020-02-01) -
Adjunctive Use of Circulating Tumor DNA Testing in Detecting Pancreas Cancer Recurrence
by: Aixa E. Soyano, et al.
Published: (2019-02-01) -
Blood-Based Cancer Biomarkers in Liquid Biopsy: A Promising Non-Invasive Alternative to Tissue Biopsy
by: José Marrugo-Ramírez, et al.
Published: (2018-09-01)